Trial Profile
A Phase 1, Open-Label, Randomized, Single Oral Dose, Three-Way Crossover Study to Assess the Effect of Food on the Pharmacokinetics of Mirabegron.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2013
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder; Urination disorders
- Focus Pharmacokinetics
- 21 Jul 2009 New trial record